Coding for COVID-19 Vaccine Shots | CMS

After the FDA issues an emergency use authorization (EUA) or approveslicensure of each COVID-19 vaccine product, CMS will identify the following for Medicare payment:

CMS and the American Medical Association (AMA) collaborated on a new approach to report use of COVID-19 vaccines.If you planto administer the COVID-19 vaccinesor the monoclonal antibody infusions, especially if you plan to roster bill these codes,download and install the newest release of PC-ACE (PDF). This release includes the coding structure, currently comprised of both of these:

Together, these codes support the administration of the COVID-19 vaccines and the monoclonal antibody infusions, as they become available. CMS and the AMA developed this code structureto make claims processingfor COVID-19 vaccines and monoclonal antibody infusions that get FDA EUA or FDA approval more efficient. Most of these codes aren't currently effective and we won't use all codes.We'll issue specific code descriptors in the future.Medicare effective dates for the codeswill match with the date of the FDA EUA or FDA approval.

Get the most current list of billing codes, payment allowances and effective dates.

Use HCPCS Level II code M0201 for the additional payment for administering the COVID-19 vaccine to certain Medicare patients in their homes.

See the original post:

Coding for COVID-19 Vaccine Shots | CMS